about
Neuropathology of non-Alzheimer degenerative disordersTau-associated neuropathology in ganglion cell tumours increases with patient age but appears unrelated to ApoE genotypeMolecular characterization of a novel human hybrid-type receptor that binds the alpha2-macroglobulin receptor-associated proteinBrain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's diseaseIntroduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein EA novel functional role for apolipoprotein B in male infertility in heterozygous apolipoprotein B knockout miceThe low density lipoprotein receptor gene family. Differential expression of two alpha2-macroglobulin receptors in the brainInhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cellsCognitive impairment among World Trade Center responders: long-term implications of re-experiencing the 9/11 terrorist attacksNeuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's diseaseBrain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study.Safety and efficacy assessment of standardized herbal formula PM012.Accessing genomic data through XML-based remote procedure calls.Analysis of genetic linkage data for Mendelian traits.Straightforward detection of SNPs in double-stranded DNA by using exonuclease III/nuclease S1/PNA system.Apolipoprotein E4 as a predictor of outcomes in pediatric mild traumatic brain injuryThe tRNA(Gln) 4336 mitochondrial DNA variant is not a high penetrance mutation which predisposes to dementia before the age of 75 years.The butyrylcholinesterase K variant and susceptibility to Alzheimer's diseaseIncreased Amyloid Precursor Protein and Tau Expression Manifests as Key Secondary Cell Death in Chronic Traumatic Brain Injury.Type 2 diabetes as a risk factor for cognitive impairment: current insights.Cerebrospinal fluid biomarkers in mild cognitive impairment and dementiaRole of macrophage activation in the pathogenesis of Alzheimer's disease and human immunodeficiency virus type 1-associated dementia.ACAT inhibition and amyloid beta reduction.Seizures and epilepsy in Alzheimer's diseaseHaplotypes at ATM identify coding-sequence variation and indicate a region of extensive linkage disequilibrium.Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shiftNeuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases.Structural variation in human apolipoprotein E3 and E4: secondary structure, tertiary structure, and size distribution.Possible Alzheimer's disease in an apolipoprotein E2 homozygote.Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapyProbable early-onset Alzheimer's disease in an apolipoprotein E2 homozygoteSecretases as targets for drug design in Alzheimer's disease.Effect of apolipoprotein E on the cerebral load of latent herpes simplex virus type 1 DNAEstrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.HDL mimetic peptide ATI-5261 forms an oligomeric assembly in solution that dissociates to monomers upon dilutionPharmacogenomics for the treatment of dementia.Apolipoprotein E isoform-dependent dendritic recovery of hippocampal neurons following activation of innate immunity.Decreased white matter integrity in neuropsychologically defined mild cognitive impairment is independent of cortical thinning.Evaluation of the global association between cholesterol-associated polymorphisms and Alzheimer's disease suggests a role for rs3846662 and HMGCR splicing in disease risk.Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex
P2860
Q24657571-2F184B62-86DD-4A1A-AAEF-BF99D37D6B3CQ28211236-E58A15EC-6AE4-4555-99AE-5B08189C76F8Q28298111-1A70D603-4C9D-42B6-B1D8-25BA1C6C1B9CQ28345684-CDF31DA8-8D9B-448D-AA10-232740DC741EQ28508278-3345B12A-9A9B-447F-8438-197BCCDA7954Q28508453-10F7E2E8-C355-4177-A5CA-EFEC73EB3B66Q28575743-EC718AF8-26F7-4475-8975-257DCF18390AQ28771380-04D4DFFD-2963-4F30-BC75-B635AFC87D43Q28950649-A5B7B920-3008-4689-BE58-C1D487248EF1Q30054419-2ECD56B8-F49B-4971-9A66-19474B39B431Q30435790-F23148CD-86C1-42BD-B9B3-C4DF3B5610F5Q30513935-8EDAC7E6-E3B7-4B7B-827E-E57D5F176C62Q30751688-2A5CCD73-EC8B-4D4A-8824-05E53A53C606Q30856799-394EBB27-996A-4BA4-AD4E-FE6F4EEA395FQ33198616-05EAF433-801F-4593-B3FE-99526CE8995DQ33657778-4B2E5039-ADCD-4683-9C34-D1A436EC12ABQ33678113-2CB3BF6B-9D3F-4780-B119-88298903F89CQ33681727-84BF74B8-BB7C-428E-BD37-86242396EA26Q33834046-994568C8-C05C-4FD3-BA12-04455C1C992AQ33857774-800CEAC6-496E-48FF-AA1C-E9EE53ED89C5Q33936708-36BB9A5E-08FF-46AF-8522-5E5D387BCC3FQ33940352-4D27CABE-DA38-4BD5-9224-F0269EAB0F69Q34052308-BB3564C1-6D40-4833-9F08-84D5DD9B8F3DQ34070798-9020DAFB-CE30-4084-88D0-615369688AB2Q34144298-1F2126B3-AA2E-4CE7-93EB-E931E26D6363Q34160589-E2EC8AC9-07E1-4EB8-BDBA-A22065B3E340Q34179881-8BF97618-309C-4B25-8328-6BF263BFBDE6Q34188538-5D0FDC68-2EB4-4E0B-AF2D-96982AAA1FF4Q34198068-AB56C56D-414E-4A59-8DAD-2AE9E4150ADCQ34219814-F17AC648-EA6F-4CBA-A8C1-E73C2FC94F25Q34354478-2DCB9EE2-2305-4F36-B8BD-F4A1AC83E191Q34536036-A4EB5162-6328-435B-BCFD-E3BF33122401Q34648195-7034AFB1-9032-4F34-8631-FDF889A8932BQ34784469-EBFBCAF6-B36D-426C-89C4-E7F91B9E5624Q35001010-BFB9A244-70EC-424F-B9E2-48EE6805CE6BQ35009345-7C2DC508-7E11-4D95-91C7-CABD90C64ADDQ35060115-FDE2D273-B935-4831-9A50-8E956B601A97Q35167339-C557D361-BB85-44D8-AFC4-3C402A3DBD3BQ35232774-6AC83A69-CF62-404F-AD8E-530879A1F7F3Q35238425-ABBD93EC-82D7-400A-A068-AD15937C2257
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
name
Apolipoprotein E and Alzheimer disease
@ast
Apolipoprotein E and Alzheimer disease
@en
Apolipoprotein E and Alzheimer disease
@nl
type
label
Apolipoprotein E and Alzheimer disease
@ast
Apolipoprotein E and Alzheimer disease
@en
Apolipoprotein E and Alzheimer disease
@nl
prefLabel
Apolipoprotein E and Alzheimer disease
@ast
Apolipoprotein E and Alzheimer disease
@en
Apolipoprotein E and Alzheimer disease
@nl
P2860
P3181
P356
P1476
Apolipoprotein E and Alzheimer disease
@en
P2093
W J Strittmatter
P2860
P304
P3181
P356
10.1073/PNAS.92.11.4725
P407
P577
1995-05-23T00:00:00Z